Innovision Limited Schedules Board Meeting on April 13, 2026 for Q3FY26 Financial Results Review
Innovision Limited has announced a board meeting for April 13, 2026, to review and approve unaudited financial results for Q3FY26 and nine months ended December 31, 2026. The meeting follows regulatory compliance under SEBI guidelines, with trading window restrictions in place for designated persons since March 23, 2026, remaining closed until 48 hours after audited results declaration for the year ended March 31, 2026.

*this image is generated using AI for illustrative purposes only.
Innovision Limited has formally notified stock exchanges about an upcoming board meeting to review its quarterly financial performance, marking a key milestone in the company's regulatory compliance schedule.
Board Meeting Details
The company has scheduled a board of directors meeting for Monday, April 13, 2026, in compliance with Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The meeting agenda includes specific items related to financial reporting and corporate governance.
| Meeting Parameter: | Details |
|---|---|
| Date: | Monday, April 13, 2026 |
| Primary Agenda: | Unaudited Financial Results Review |
| Reporting Period: | Q3FY26 and Nine Months Ended December 31, 2026 |
| Results Type: | Standalone and Consolidated |
Key Agenda Items
The board will primarily focus on two main areas during the scheduled meeting. The directors will consider and approve the unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2026, along with the Limited Review Report from statutory auditors. Additionally, the meeting will address any other matters that may require board attention.
Trading Window Restrictions
In accordance with regulatory requirements, Innovision Limited has implemented trading restrictions for designated persons. The trading window for dealing in company securities has been closed for designated persons and their immediate relatives since March 23, 2026, which coincides with the company's listing date.
| Trading Window Details: | Information |
|---|---|
| Closure Date: | March 23, 2026 |
| Applicable To: | Designated Persons and Immediate Relatives |
| Reopening: | 48 hours after audited results declaration |
| Results Reference: | Quarter and Year ended March 31, 2026 |
Regulatory Compliance
The announcement demonstrates the company's adherence to multiple regulatory frameworks. The notification complies with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, and follows the company's Code of Conduct alongside SEBI (Prohibition of Insider Trading) Regulations, 2015. The company has made this intimation available on its official website and has formally notified both BSE Limited and National Stock Exchange of India Limited about the scheduled meeting.
How might Innovision's Q3FY26 performance impact its stock price trajectory following the results announcement?
What strategic initiatives could Innovision announce alongside its quarterly results to drive future growth?
Will the company's recent listing status influence investor expectations for its first major quarterly disclosure?




























